These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 4136737

  • 1. Five years' experience with iodine-125 therapy of Graves' disease.
    Weidinger P, Johnson PM, Werner SC.
    Lancet; 1974 Jul 13; 2(7872):74-7. PubMed ID: 4136737
    [No Abstract] [Full Text] [Related]

  • 2. Hypothyroidism following iodine-131 therapy.
    Hayes MT.
    J Nucl Med; 1982 Feb 13; 23(2):176-9. PubMed ID: 6173470
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Graves' Disease: Can It Be Cured?
    Wiersinga WM.
    Endocrinol Metab (Seoul); 2019 Mar 13; 34(1):29-38. PubMed ID: 30912336
    [Abstract] [Full Text] [Related]

  • 6. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
    Mitouze J, Jaffiol C, Baldet L, Ghachem M.
    Rev Fr Endocrinol Clin; 1972 Mar 13; 13(4):339-61. PubMed ID: 4122472
    [No Abstract] [Full Text] [Related]

  • 7. Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
    Cevallos JL, Hagen GA, Maloof F, Chapman EM.
    N Engl J Med; 1974 Jan 17; 290(3):141-3. PubMed ID: 4859623
    [No Abstract] [Full Text] [Related]

  • 8. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ, Ladenson PW.
    J Clin Endocrinol Metab; 1986 Jul 17; 63(1):102-6. PubMed ID: 2423547
    [Abstract] [Full Text] [Related]

  • 9. Efficiency analysis of using tailored individual doses of radioiodine and fine tuning using a low-dose antithyroid drug in the treatment of Graves' disease.
    Liu CJ, Dong YY, Wang YW, Wang KH, Zeng QY.
    Nucl Med Commun; 2011 Mar 17; 32(3):227-32. PubMed ID: 21191313
    [Abstract] [Full Text] [Related]

  • 10. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
    Körber C, Schneider P, Körber-Hafner N, Hänscheid H, Reiners C.
    Eur J Nucl Med; 2001 Sep 17; 28(9):1360-4. PubMed ID: 11585295
    [Abstract] [Full Text] [Related]

  • 11. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA, Gross JL, Maia AL.
    J Clin Endocrinol Metab; 2001 Aug 17; 86(8):3488-93. PubMed ID: 11502768
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
    Sridama V, McCormick M, Kaplan EL, Fauchet R, DeGroot LJ.
    N Engl J Med; 1984 Aug 16; 311(7):426-32. PubMed ID: 6205272
    [Abstract] [Full Text] [Related]

  • 13. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK, Larsen PR.
    J Clin Endocrinol Metab; 2002 Mar 16; 87(3):1073-7. PubMed ID: 11889166
    [Abstract] [Full Text] [Related]

  • 14. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F, Martino E, Bartalena L.
    J Endocrinol Invest; 2003 Feb 16; 26(2):174-6. PubMed ID: 12739747
    [No Abstract] [Full Text] [Related]

  • 15. T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.
    Bagnasco M, Canonica GW, Ferrini S, Biassoni P, Melioli G, Ferrini O, Giordano G.
    Acta Endocrinol (Copenh); 1983 Feb 16; 102(2):213-9. PubMed ID: 6187169
    [Abstract] [Full Text] [Related]

  • 16. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
    Tamai H, Nakagawa T, Takahashi H, Ohsako N, Fukino O, Shinzato R, Suematsu H, Matsuzuka F, Kuma K, Nagataki S.
    J Nucl Med; 1980 Mar 16; 21(3):240-5. PubMed ID: 6892713
    [No Abstract] [Full Text] [Related]

  • 17. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
    Hu RT, Liu DS, Li B.
    BMC Endocr Disord; 2020 May 29; 20(1):76. PubMed ID: 32471411
    [Abstract] [Full Text] [Related]

  • 18. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA, Daykin J, Holder R, Sheppard MC.
    QJM; 1995 Mar 29; 88(3):175-80. PubMed ID: 7767667
    [Abstract] [Full Text] [Related]

  • 19. Hyperthyroidism due to Graves-Basedow disease in a woman refractory to thyroid hormones.
    González Cabrera N, Kalic AK, Antón Miguel MÁ, Sierra Polo P, Vicente Vicente MÁ.
    Endocrinol Nutr; 2012 Dec 29; 59(10):609-11. PubMed ID: 22425314
    [No Abstract] [Full Text] [Related]

  • 20. 125I therapy in Graves' disease. Long-term results in 355 patients.
    McDougall IR, Greig WR.
    Ann Intern Med; 1976 Dec 29; 85(6):720-3. PubMed ID: 1036667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.